It is now well known that rheumatoid factors (RF) or antigamma globulin antibodies are found in many individuals with a wide variety of diseases other than rheumatoid arthritis (Bartfeld, 1960 (Bartfeld, , 1969 Oreskes and Spiera, 1966, 1967) . In many of these diseases the presence of RF seems to be related to a previous or concurrent history of chronic antigenic stimulation. Examples of this include cases of subacute bacterial endocarditis (Williams and Kunkel, 1962) and tuberculosis (Singer, Plotz, Peralta, and Lyons, 1962) , as well as diabetics on long-term insulin therapy (Oreskes and Spiera, 1973) . Similarly, RF is present in patients who have received multiple transfusions (Vierucci, 1965) or vaccinations (Aho, Konttinen, Rajasalmi, and Wager, 1962) . Tuffanelli (1968) , Nickerson, Williams, Boxmeyer, and Quie (1970) , and Ryan, Parker, and Williams (1972) have reported significant levels of RF activity in heroin addicts. Typically, individuals who are addicted to heroin repeatedly inject themselves with heroin which may also contain other foreign substances. It is a plausible view that heroin or its adulterants are antigenic, or may become antigenic by forming complexes with endogenous protein. Therefore, one might expect in many of these individuals production of antibodies to these antigens. Resultant antigen-antibody complexes could in turn serve as the stimulus for RF production.
An alternative possibility is that RF in heroin addicts is in some way related to the liver dysfunction commonly seen in such individuals. Correlation of RF activity and liver disease has been frequently reported (Bartfeld, 1969) .
The purpose of the present study was to follow the course of RF in heroin-dependent persons on methadone maintenance to obtain additional information regarding the pathogenic mechanism of RF production. (Stimmel, Bernstein, and Tobias, 1972 (Rose, Ragan, Pearce, and Lipman, 1948) All patients were monitored twice a week by thin-layer chromatography of urine to determine the presence of morphine, barbiturates, amphetamines, quinine, and methadone. Patients whose urine was positive for any of these drugs other than methadone were excluded from the study. Latex-fixation and liver function tests were repeated after about 1 year on the patients remaining in the study. (Oreskes and Siltzbach, 1968) . Tuffanelli (1968) noted the presence of RF activity in narcotic addicts. Nickerson and others (1970) reported positive latex-fixation tests in 9 of 25 (32 per cent.) heroin addicts. In a later series of addicts, Ryan and others (1972) Ryan and others (1972) have shown that serum immunoglobulin G (IgG) derived from heroin addicts specifically bind morphine (diacetyl heroin), and suggested that an immune response to morphine occurs in some patients addicted to heroin or its analogs. These investigators also showed that normal IgG could also bind morphine, but more weakly.
Results

Measurement
These observations suggest that heroin may bind nonspecifically to serum proteins, and that heroin in this Rheumatoidfactor activity in heroin addicts on methadone maintenance 155 form could behave as a hapten. With repeated injections of heroin, the host is subjected to chronic antigenic stimulation. In the present study, after 1 year during which the patients no longer 'immunized' themselves (that is, they stopped injecting heroin), 21 of 32 (66 per cent.) who were originally RF positive converted to negative.
In the experimental animal repeated injection of a foreign protein results in the production of specific antibody to the injected antigen followed by the production of rheumatoid-like factors (Abruzzo and Christian, 1961; Aho and Wager, 1961) . When the injection of foreign protein is halted, the titre of the rheumatoid-like factors soon decreases markedly. Thus the disappearance of RF in the heroin addict may be related to the cessation of the immune stimulus, that is, the cessation of heroin injections.
The RF present in patients with conditions other than rheumatoid arthritis differs in respect to antigenic specificity, quantity, and constancy from RF in patients with rheumatoid arthritis. In rheumatoid arthritis, RF reacts with both rabbit and human IgG; it is present in high titre (the mean titre of RF among patients with definite rheumatoid arthritis in our laboratory is 1: 2,560), and remains constant independent of the course of the disease, that is, during periods of remission or exacerbation. In diseases other than rheumatoid arthritis, RF tends to react only with human IgG: RF is present in lower titre (mean = 1: 160) (Oreskes and Siltzbach, 1968s , and tends to disappear when the underlying illness is cured or is in remission. In respect to two of these three features, RF in the heroin group behaves like RF found in diseases other than rheumatoid arthritis. Only in the high number of positive tests obtained with the sensitized sheep cell procedure (reactivity with rabbit IgG) does the RF of heroin addicts resemble the RF of rheumatoid arthritis. But here, too, titres were lower than those usually encountered in rheumatoid arthritis.
In seven patients whose sera were negative on initial testing, the reaction became positive a year later, presumably because oftransient virus infections. Transient production of rheumatoid factor under these circumstances has been described (Bartfeld, 1969) . The failure to find a higher incidence of RF in these addicts after 1 year of oral methadone treatment suggests that this regimen does not stimulate RF production.
Of interest is the recent report of Cushman and Grieco (1973) , who demonstrated that 69 per cent. of 109 heroin addicts seeking methadone maintenance exhibited high levels of serum immunoglobulin M (IgM) which did not correlate with manifest liver disease or elevated GOT or AP levels. A prospective study of 21 patients showed a drop in mean IgM levels during methadone maintenance. It may be noted that, in the present study, treatment with mercaptoethanol abolished all RF activity, suggesting that in our group the RF was of the 1gM variety.
The presence of other serological abnormalities in heroin users, such as biological false positive reactions, hypergammaglobulinaemia, and febrile agglutinins, is well known, and suggests a protean disorder in the immunoproliferative system (Boak, Carpenter, and Miller, 1961; Cherubin and Millian, 1968; Vogel, Cherubin, and Millian, 1970; Nickerson and others, 1970) . Alteration in cellular immune function, reflected by impaired responsiveness in lymphocyte culture to phytohaemagglutinin, has also been reported (Brown, Stimmel, Taub, and Kochwa, 1970) .
Judging from our data, the presence of RF in the sera of drug addicts is best explained on the basis of chronic antigenic stimulation. This process is comparable to production of RF in diabetic patients on insulin (Oreskes and Spiera, 1973) , and in individuals subjected to repeated blood transfusions (Vierucci, 1965) . The sequence of events appears to be: primary antigenic stimulation, primary antibody response, formation of antigen-antibody complexes, and finally RF production directed against altered IgG in the original antigen-antibody complex. It would appear that this process occurs in many individuals with a wide variety of diseases, thus making rheumatoid factor production a very widespread immunological phenomenon.
Summary
In a prospective study of heroin users upon entry into a methadone maintenance treatment program, 47 of 163 (29 per cent.) exhibited significant titres of rheumatoid factor activity with the latex-fixation test, which was unrelated to the presence of liver dysfunction, hyperglobulinaemia, or biological false positive serological reaction. After 1 year of oral methadone maintenance in the absence of continued heroin injection, 21 of 32 addicts initially positive for rheumatoid factor became negative. These results are consistent with previous clinical and animal studies, and suggest that rheumatoid factor production is associated in these individuals with their previous history of heroin injection. Cessation of heroin injection appears to remove the stimulus for rheumatoid factor production. 
